These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10477682

  • 1. Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis.
    Haseyama Y, Sawada Ki, Oda A, Koizumi K, Takano H, Tarumi T, Nishio M, Handa M, Ikeda Y, Koike T.
    Blood; 1999 Sep 01; 94(5):1568-77. PubMed ID: 10477682
    [Abstract] [Full Text] [Related]

  • 2. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells.
    Myklebust JH, Blomhoff HK, Rusten LS, Stokke T, Smeland EB.
    Exp Hematol; 2002 Sep 01; 30(9):990-1000. PubMed ID: 12225790
    [Abstract] [Full Text] [Related]

  • 3. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
    Bouscary D, Pene F, Claessens YE, Muller O, Chrétien S, Fontenay-Roupie M, Gisselbrecht S, Mayeux P, Lacombe C.
    Blood; 2003 May 01; 101(9):3436-43. PubMed ID: 12506011
    [Abstract] [Full Text] [Related]

  • 4. The signaling pathways of erythropoietin and interferon-gamma differ in preventing the apoptosis of mature erythroid progenitor cells.
    Paiboonsukwong K, Choi I, Matsushima T, Abe Y, Nishimura J, Winichagoon P, Fucharoen S, Nawata H, Muta K.
    Int J Hematol; 2003 Dec 01; 78(5):421-8. PubMed ID: 14704034
    [Abstract] [Full Text] [Related]

  • 5. Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways.
    Sui X, Krantz SB, Zhao ZJ.
    Br J Haematol; 2000 Jul 01; 110(1):63-70. PubMed ID: 10930980
    [Abstract] [Full Text] [Related]

  • 6. Opposing effects of PI3 kinase pathway activation on human myeloid and erythroid progenitor cell proliferation and differentiation in vitro.
    Lewis JL, Marley SB, Ojo M, Gordon MY.
    Exp Hematol; 2004 Jan 01; 32(1):36-44. PubMed ID: 14725899
    [Abstract] [Full Text] [Related]

  • 7. Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis.
    Sui X, Krantz SB, You M, Zhao Z.
    Blood; 1998 Aug 15; 92(4):1142-9. PubMed ID: 9694701
    [Abstract] [Full Text] [Related]

  • 8. Phosphatase inhibition promotes antiapoptotic but not proliferative signaling pathways in erythropoietin-dependent HCD57 cells.
    Lawson AE, Bao H, Wickrema A, Jacobs-Helber SM, Sawyer ST.
    Blood; 2000 Sep 15; 96(6):2084-92. PubMed ID: 10979952
    [Abstract] [Full Text] [Related]

  • 9. Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax.
    Somervaille TC, Linch DC, Khwaja A.
    Blood; 2001 Sep 01; 98(5):1374-81. PubMed ID: 11520785
    [Abstract] [Full Text] [Related]

  • 10. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
    Uddin S, Kottegoda S, Stigger D, Platanias LC, Wickrema A.
    Biochem Biophys Res Commun; 2000 Aug 18; 275(1):16-9. PubMed ID: 10944433
    [Abstract] [Full Text] [Related]

  • 11. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
    Tong W, Zhang J, Lodish HF.
    Blood; 2005 Jun 15; 105(12):4604-12. PubMed ID: 15705783
    [Abstract] [Full Text] [Related]

  • 12. Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells.
    Marley SB, Lewis JL, Schneider H, Rudd CE, Gordon MY.
    Br J Haematol; 2004 May 15; 125(4):500-11. PubMed ID: 15142121
    [Abstract] [Full Text] [Related]

  • 13. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction.
    Kashii Y, Uchida M, Kirito K, Tanaka M, Nishijima K, Toshima M, Ando T, Koizumi K, Endoh T, Sawada K, Momoi M, Miura Y, Ozawa K, Komatsu N.
    Blood; 2000 Aug 01; 96(3):941-9. PubMed ID: 10910908
    [Abstract] [Full Text] [Related]

  • 14. Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin.
    Shan R, Price JO, Gaarde WA, Monia BP, Krantz SB, Zhao ZJ.
    Blood; 1999 Dec 15; 94(12):4067-76. PubMed ID: 10590051
    [Abstract] [Full Text] [Related]

  • 15. Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation.
    Laubach JP, Fu P, Jiang X, Salter KH, Potti A, Arcasoy MO.
    Exp Hematol; 2009 Dec 15; 37(12):1411-22. PubMed ID: 19815050
    [Abstract] [Full Text] [Related]

  • 16. Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells.
    Fukumoto T, Kubota Y, Kitanaka A, Yamaoka G, Ohara-Waki F, Imataki O, Ohnishi H, Ishida T, Tanaka T.
    Cell Signal; 2009 Dec 15; 21(12):1775-83. PubMed ID: 19665053
    [Abstract] [Full Text] [Related]

  • 17. Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways.
    Miljus N, Heibeck S, Jarrar M, Micke M, Ostrowski D, Ehrenreich H, Heinrich R.
    Neuroscience; 2014 Jan 31; 258():218-27. PubMed ID: 24269933
    [Abstract] [Full Text] [Related]

  • 18. [Reversal effect of PI-3K/Akt pathway inhibitor LY294002 on multidrug resistance of ovarian cancer cell line A2780/Taxol].
    Shi XY, Cai XJ, Lei JX, Cao FJ, Pan DF, Chen P.
    Ai Zheng; 2008 Apr 31; 27(4):343-7. PubMed ID: 18423117
    [Abstract] [Full Text] [Related]

  • 19. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
    Das R, Mahabeleshwar GH, Kundu GC.
    J Biol Chem; 2003 Aug 01; 278(31):28593-606. PubMed ID: 12771144
    [Abstract] [Full Text] [Related]

  • 20. Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc.
    Chen C, Sytkowski AJ.
    J Biol Chem; 2001 Oct 19; 276(42):38518-26. PubMed ID: 11483613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.